(800) 526-OPYS Pay my bill Member login
logo
OPYS 10 years
  • Hospital Solutions
    • Emergency Medicine
    • Hospital Medicine
    • Telemedicine
    • Urgent Care
    • Post Acute Care
    • Correctional Medicine
    • Locum Tenens
  • Join our Team
    • Physicians
    • Advanced Practitioners
    • Career Opportunities
  • About OPYS
    • Experienced Group
    • Metrics & Outcomes
    • Throughout the US
    • Quality Patient Care
    • Clinical Performance
    • Qualified Providers
    • Company Profile
    • Leadership Team
    • Mission Statement
    • Reviews
  • News
  • Contact Us

Does Fetal Cannabis Exposure Affect Metabolism?

Home > Women's Health > Does Fetal Cannabis Exposure Affect Metabolism?

Does Fetal Cannabis Exposure Affect Metabolism?

January 23, 2023

Cannabis is becoming more popular as laws around its use are relaxed and more and more cannabis-based products hit the market. Given the increased use and growing perception that cannabis use is safe, it is critical that we accelerate research into understanding the specific effects of cannabis use and the contexts in which it may be helpful or harmful.

A new study published in the Journal of Clinical Endocrinology and Metabolism has addressed the issue of how fetal exposure to cannabis may impact children from a metabolic standpoint. While reported cannabis use amongst pregnant women in the United States rose from 3.4% in 2002 to 7% in 2017, experts suspect that self-reported estimates may underrepresent the actual use of cannabis amongst pregnant women. One study conducted in 2016 found that THC could be detected in between 1 and 4 and 1 and 5 pregnant women.

While previous research has suggested that neonates who are born to cannabis users may be lower birth weight, little is known about how these children’s metabolisms work as they grow older. One group of researchers, along with a handful of physicians suggested that the intrauterine growth restriction that may occur in fetuses of mothers who use cannabis could lead to compensatory growth after birth. Such catch-up growth could put these children at a heightened risk for obesity, diabetes, and metabolic syndrome.

To address this question, the scientists studied 103 mother and child pairs from a Colorado-based cohort. They found that 15% of the women they studied had detectable levels of cannabinoids that would indicate fetal exposure to cannabis. The offspring who had been exposed to cannabis had significantly higher levels of fat mass, fat-free mass, adiposity, and fasting glucose than those who had not been exposed to cannabis when they were assessed at follow-up. The average follow-up age was 4.7 years.

While the results of this study suggest that there may be an association between fetal cannabis exposure and great weight in childhood, it did not establish an association between cannabis exposure and BMI. Given that pregnant women are using cannabis in the United States more now than they have in previous years, it is important that we work to understand how cannabis affects pregnant women and the children who are exposed to cannabis in utero.

 

 

 

Reference

Moore BF, Sauder KA, Shapiro ALB, Crume T, Kinney GL, Dabelea D. Fetal Exposure to Cannabis and Childhood Metabolic Outcomes: The Healthy Start Study. The Journal of Clinical Endocrinology & Metabolism. Published online March 31, 2022. doi:10.1210/CLINEM/DGAC101

Filed Under: General, Patient Care, Public Health, Women's Health Tagged With: Health care, Medications, OPYS, patient care, Pediatrics

Search

Categories

  • Best Practice
  • Cardiologists
  • COVID-19
  • Emergency Physicians
  • General
  • Health Technology
  • Hospital Physicians
  • Hospitalists
  • New Job Opportunities
  • Nurses
  • Patient Care
  • Physician Job
  • Physician Services News
  • Public Health
  • Reimbursement
  • Telehealth Blog Series
  • Women's Health

Archives

  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • April 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • September 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • December 2017
  • March 2017
  • June 2016
  • August 2015
  • December 2011
  • November 2011
  • October 2011
  • September 2011
  • August 2011
  • July 2011
  • June 2011
  • May 2011
  • April 2011
  • March 2011
  • February 2011

We’d Love to Hear From You,
Get In Touch With Us!

logo

Since 2012, providing quality, efficient, patient-centered healthcare through experienced medical leadership, communication, and collaboration in the provision of hospital-based physician outsourcing services.

Our Services
  • Emergency Medicine
  • Hospital Medicine
  • Telemedicine
  • Urgent Care
  • Post Acute Care
  • Correctional Medicine
OPYS Advantage
  • Our Team
  • Investor Relations
  • Career Opportunities
Contact
Corporate Office 

One Indiana Square, Suite 2060
Indianapolis, IN 46204

Phone: (800) 526-6797
Fax: (800) 456-6148
Email: info@opys.com

Copyright © 2012 - 2022. All rights reserved I Site Map I Privacy Policy I Terms and Use